Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $8.57 Consensus Price Target from Analysts
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has received a consensus recommendation of “Hold” from the ten analysts that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have issued a buy recommendation and one has given a strong […]
24 Aug 02:58 · The Cerbat Gem